Literature DB >> 26910379

Mammalian prion amyloid formation in bacteria.

Bruno Macedo1,2, Yraima Cordeiro2, Salvador Ventura1.   

Abstract

Mammalian prion proteins (PrPs) that cause transmissible spongiform encephalopathies are misfolded conformations of the host cellular PrP. The misfolded form, the scrapie PrP (PrP(Sc)), can aggregate into amyloid fibrils that progressively accumulate in the brain, evolving to a pathological phenotype. A particular characteristic of PrP(Sc) is to be found as different strains, related to the diversity of conformational states it can adopt. Prion strains are responsible for the multiple phenotypes observed in prion diseases, presenting different incubation times and diverse deposition profiles in the brain. PrP biochemical properties are also strain-dependent, such as different digestion pattern after proteolysis and different stability. Although they have long been studied, strain formation is still a major unsolved issue in prion biology. The recreation of strain-specific conformational features is of fundamental importance to study this unique pathogenic phenomenon. In our recent paper, we described that murine PrP, when expressed in bacteria, forms amyloid inclusion bodies that possess different strain-like characteristics, depending on the PrP construct. Here, we present an extra-view of these data and propose that bacteria might become a successful model to generate preparative amounts of prion strain-specific assemblies for high-resolution structural analysis as well as for addressing the determinants of infectivity and transmissibility.

Entities:  

Keywords:  amyloid; bacteria; inclusion body; prion; recombinant; strain; transmission

Mesh:

Substances:

Year:  2016        PMID: 26910379      PMCID: PMC4981191          DOI: 10.1080/19336896.2016.1141859

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  38 in total

1.  Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

Authors:  G P Saborio; B Permanne; C Soto
Journal:  Nature       Date:  2001-06-14       Impact factor: 49.962

Review 2.  Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases.

Authors:  Jing L Guo; Virginia M Y Lee
Journal:  Nat Med       Date:  2014-02       Impact factor: 53.440

3.  Aggregation interplay between variants of the RepA-WH1 prionoid in Escherichia coli.

Authors:  Laura Molina-García; Rafael Giraldo
Journal:  J Bacteriol       Date:  2014-05-02       Impact factor: 3.490

Review 4.  Spreading of pathology in neurodegenerative diseases: a focus on human studies.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2015-01-15       Impact factor: 34.870

5.  Generating a prion with bacterially expressed recombinant prion protein.

Authors:  Fei Wang; Xinhe Wang; Chong-Gang Yuan; Jiyan Ma
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

6.  RepA-WH1 prionoid: a synthetic amyloid proteinopathy in a minimalist host.

Authors:  Rafael Giraldo; Susana Moreno-Díaz de la Espina; M Elena Fernández-Tresguerres; Fátima Gasset-Rosa
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

7.  Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters.

Authors:  R Hecker; A Taraboulos; M Scott; K M Pan; S L Yang; M Torchia; K Jendroska; S J DeArmond; S B Prusiner
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

8.  Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.

Authors:  Jason M Wilham; Christina D Orrú; Richard A Bessen; Ryuichiro Atarashi; Kazunori Sano; Brent Race; Kimberly D Meade-White; Lara M Taubner; Andrew Timmes; Byron Caughey
Journal:  PLoS Pathog       Date:  2010-12-02       Impact factor: 6.823

9.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

10.  Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation.

Authors:  Alba Espargaró; Raimon Sabate; Salvador Ventura
Journal:  Mol Biosyst       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.